remede® System

FDA Premarket Approval P160039 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Of a change to the gen 1. 5 ipg firmware (fw) from version 1. 13 to version 1. 14

Deviceremede® System
Generic NameImplanted Phrenic Nerve Stimulator For Central Sleep Apnea
ApplicantRESPICARDIA
Date Received2021-08-06
Decision Date2022-01-10
PMAP160039
SupplementS007
Product CodePSR 
Advisory CommitteeAnesthesiology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address RESPICARDIA 12400 Whitewater Drive suite 150 minnetonka, MN 55343

Supplemental Filings

Supplement NumberDateSupplement Type
P160039Original Filing
S007 2021-08-06 Normal 180 Day Track
S006 2021-01-19 Normal 180 Day Track
S005 2019-08-20 Normal 180 Day Track
S004 2018-10-16 Normal 180 Day Track
S003 2018-05-01 Normal 180 Day Track
S002 2018-02-27 Normal 180 Day Track
S001 2017-10-30 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00857688007346 P160039 000
00857688007384 P160039 000
00857688007001 P160039 000
00857688007063 P160039 000
00857688007070 P160039 000
00857688007230 P160039 000
00857688007315 P160039 000
00857688007322 P160039 000
00857688007339 P160039 000
00857688007407 P160039 006
00857688007414 P160039 006
00857688007421 P160039 006
00857688007438 P160039 006
00857688007445 P160039 006
00857688007452 P160039 006
00857688007469 P160039 006
00857688007483 P160039 006
00857688007490 P160039 006
00857688007391 P160039 006

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.